Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in the Nordic Countries, Denmark, Finland, Iceland, Norway and Sweden, or involving organisations from these countries.

Total search results: 955 | Ordered by Date (descending)
next pagenext page 1 2 3 4 5 6 7 8 9 10  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Unisensor–Philips: investment, 201407– acquisition €na to become part of Philips Healthcare Incubator ANNOUNCED 2014-07-24
International Council of Biotechnology Associations–Norwegian Bioindustry Association: biotechnology, 201407 NBA is founding member of ICBA 2014-07-10
Nordic Nanovector–Holta Invest: investment, 201407 investment by Holta Life Sciences 2014-07-01
Univ Copenhagen–Thermo Fisher: mass spectrometer, 201406 supply existent Jesper Olsen at NNF CPR has been early-access user of Q Exactive HF system 2014-06-16
BioSilta–SEVERAL: investment, 201406 financing round €2.5m from Omega Funds + Inveni Capital 2014-06-11
Gilead–Genmab: antibody technology, 201406– collab €na research using + evaluating DuoBody + HexaBody platforms 2014-06-04
Gilead–Genmab: antibody technology, 201608– license + license option $5m upfront for bispecific antibody HIV drugs using DuoBody techology 2014-06-04
Chelsea Therapeutics–Lundbeck: investment, 201405–201406 acquisition tender offer up to $658m w $530m upfront cash + milestone-based CVRs 2014-05-08
Enterome–SEVERAL: investment, 201405 financing round Series B €10m led by Seventure Partners + Lundbeckfond Ventures 2014-05-01
OxThera–SEVERAL: investment, 201404 financing round SEK70m led by Kurma Biofund II incl IdInvest Partners + Mayo Clinic et al 2014-04-16
Topotarget–BioAlliance Pharma: investment, 201404–201407 merger into Onxeo w former Topotarget owners holding 1/3 ownership of new firm 2014-04-16
Wilson Therapeutics–SEVERAL: investment, 201404 financing round Series B $40m co-led by new investors Abingworth + MVM 2014-04-16
Almirall–InDex Pharmaceuticals: Kappaproct, 201404– license European marketing rights total deal value incl milestones €100m 2014-04-01
Univ Oulu–Waters: mass spectrometer, 201403 supply existent Synapt G2 HDMS Q-Tof listed on web site of MS Core Facility 2014-03-30
Genmab–MAB Discovery: drug discovery services, 201403– collab €na generation of antibodies for multiple Genmab targets 2014-03-27
DiaSpect–EKF Diagnostics: investment, 201403–201404 acquisition upfront £10.25m in cash + £5.75m + £1.425m in Jan 2015 2014-03-20
BerGenBio–SEVERAL: investment, 201402 financing round NOK75m=$12.5m from new + existing investors 2014-02-04
Genmab–SEVERAL: investment, 201401 private placement DKK998m (€133m) with 4.6m new shares for DKK217/share 2014-01-23
BPCE–SEVERAL: investment, 201401 launch €120m Seventure Health for Life Capital Fund incl investors Danone + Tereos + Tornier + Natixis + Unigrains 2014-01-20
Lilly–Genmab: bispecific antibodies, 201401– collab €na use + in-house evaluation of DuoBody technology platform by Lilly 2014-01-14
Probi–Symrise: investment, 201401– mandatory offering SEK40.1/share for all remaining shares of Probi AB after increase of Symrise holdings to 30.03% 2014-01-10
Roche–Santaris Pharma: LNA technology, 201401– collab $10m upfront + $138m milestones + royalties ww discovery + developm of RNA-targeted medicines 2014-01-09
Isarna Therapeutics–Santaris Pharma: LNA technology, 201401– license for use to discovery + develop + market TGF beta targeting immunotherapies 2014-01-08
Immunicum–SEVERAL: investment, 2014 5th financing round SEK100m 2014-01-01
Lytix Biopharma–SEVERAL: investment, 201312 capital increase NOK50m 2013-12-04
Therapure Biopharma–Upfront Chromatography: EBA chromatography, 201312 acquisition assets related to human plasma fractionation 2013-12-03
Randox–Biohit: GastroPanel test, 201311– ww license to sell GastroPanel test with Randox analyzers 2013-11-27
Algeta–Bayer: investment, 201311– acquisition proposal by Bayer NOK362/share valuing Algeta equity at €2.1b 2013-11-26
Nanovi–SEVERAL: investment, 201311 investment €0.6m by SEED Capital + Vaekstfonden to bring BioXmark to proof-of-concept 2013-11-21
Sanofi–Zealand Pharma: lixisenatide, 20131 license to Lyxumia existent 2013-11-15
Labstract–Biotage: chromatography, 201311 supply installation of 1st Isolera Dalton flash chromatography system in the UK at Labstract 2013-11-11
Boehringer–Beactica: drug discovery services, 201310– collab expansion €na fragment-based drug discovery services for oncology-relevant kinases 2013-10-22
Bayer–BioInvent: antibody library, 201310 license €na extension + broadening to n-CoDeR libraries for development of therapeutic antibodies 2013-10-14
Medical Prognosis Institute–SEVERAL: investment, 201310 listing at Nasdaq OMX First North 2013-10-08
Pharmalink (SE)–Huntsworth: public relations, 201310 service existent by Citigate Dewe Rogerson 2013-10-04
Pharmalink (SE)–SEVERAL: investment, 201310 financing round Series C SEK96m (€11m) to existing investors incl Industrifonden + new investor Investinor 2013-10-04
Acino–Nordic Capital: investment, 201310– public tender offer CHF398m with CHF115/share by Avista Capital Partners + Nordic Capital 2013-10-02
Karolinska Institutet–General Electric: DNA sequencing services, 201309– supply NGS services by SeqWright Genomic Services to Karolinska 2013-09-27
Acacia Pharma–SEVERAL: investment, 201309 financing round Series B £15m led by new invesors Fidelity Biosciences + Novo A/S 2013-09-03
Technical Univ Denmark–Thermo Fisher: mass spectrometer, 201308 supply four Q Exactive LC-MS/MS + nano-LC 1000 systems to Dept of Systems Biology 2013-08-30
Technical Univ Denmark–Thermo Fisher: mass spectrometer, 201308 supply one Oribtrap Fusion Tribrid system to Dept of Systems Biology 2013-08-30
Thermo Fisher–Technical Univ Denmark: mass spectrometry, 201308– collab developm new proteomic applications with Dept of Systems Biology at DTU 2013-08-30
CLC bio–Qiagen: investment, 201308 acquisition by Qiagen 2013-08-22
BioPorto–SEVERAL: investment, 201308–201309 offering DKK70.7m with 70.7m new shares at DKK1/share 2013-08-16
PoC-HCV project–EU (govt): grant, 201308– FP7 grant €6m to develop point-of-care Hepatitis C assays 2013-08-08
PoC-HCV project–Qlucore: PoC HCV test, 201308– collab Qlucore is partner in FP7 project 2013-08-08
Novo Nordisk–Adimab: antibody technology, 201307 collab existent w regard to Adimab antibody discovery platform 2013-07-26
Pcovery–Galapagos: drug discovery services, 201307– supply services by Argenta to discovery anti-fungal agents 2013-07-16
Gyros–Merck (DE): immunoassay kits, 201307– collab developm + manufacturing + commercialisation of kits for Gyrolab platform by EMD Millipore 2013-07-15
CLC bio–SciEngines: bioinformatics, 201307 collab integration of CLC sequence analysis s/w with SciEngines Rivyera computers 2013-07-09
Forendo Pharma–SEVERAL: investment, 201306 tranched 1st investment round from Karolinska Development + Novo Seeds + Finnvera 2013-06-25
Vaccibody–SEVERAL: investment, 201306 private placement €733k to existing investors 2013-06-21
Boehringer–Karolinska Institutet: therapeutic antibody, 201306– option to acquire fully human MAb program for athersclerosis fr Athera Biotechnologies 2013-06-19
CellCura–SEVERAL: investment, 201306 private placement NOK8.4m 41.7m shares at NOK0.2/share 2013-06-13
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Scandinavia by Unilabs 2013-06-13
Unilabs–Natera: Panorama prenatal test, 201306– distribution of Panorama test in Switzerland by Unilabs 2013-06-13
Asuragen–Exiqon: real-time PCR technology, 201306– supply Service Center Agreem for use of miRCURY LNA Universal RT microRNA PCR products by Asuragen 2013-06-10
DiaGenic–Life Technologies: Thermocycler, 201306 supply acquisition of QuantStudio Dx instruments by DiaGenic 2013-06-05
Neurelis–Biotie: investment, 201306– option $1m for exclusive right to acquire Neurelis for $8.75m in shares + milestones 2013-06-04
CARDIMMUN project–EU (govt): grant, 201306– FP7 grant 3y €6m out of total project cost of €8m 2013-06-01
Istenhegyi Centre for Genetic Diagnostics–BGI: prenatal genetic test, 201305– collab offering BGI Health’s NIFTY test in Hungary 2013-05-31
Exiqon–Denmark (govt): grant, 201305– 5y grant DKK12m from Danish Technology Foundation within Danish genomics consortium 2013-05-30
BerGenBio–SEVERAL: investment, 201305 financing round $6m from existing investors 2013-05-26
Xellia Pharmaceuticals–Novo Group: investment, 201305– acquisition 100% for $700m from 3i + other investors by Novo A/S 2013-05-21
AstraZeneca–Alchemia: drug discovery services, 201304– collab using VAST technology to discover small molecules against multiple AZ targets 2013-04-23
Immunicum–SEVERAL: investment, 201304 IPO €2.5m at Nasdaq OMX First North 2013-04-22
United States (govt)–Bavarian Nordic: Imvamune®, 201304– contract up to $228m for continued supply from BARDA 2013-04-16
Avilex Pharma–Novo Group: investment, 201304 seed financing from Novo Seeds 2013-04-15
Amplidiag–Mobidiag: investment, 201304 merger in shares with Genewave SAS + Amplidiag Oy becoming subsidiaries of Mobidiag Oy 2013-04-12
Genewave–Mobidiag: investment, 201304 merger in shares with Genewave SAS + Amplidiag Oy becoming subsidiaries of Mobidiag Oy 2013-04-12
CLC bio–IBM: bioinformatics, 201304 collab product integration of IBM hardware + CLC Genomics Server s/w + Workbench s/w for sequencing analytics 2013-04-09
Danaher–CellaVision: cell analysis technology, 201304– distribution expansion digital morphology products in EMEA by Beckman Coulter 2013-04-08
Cellectricon–Alto Marketing: public relations, 201304 service existent by Alto Marketing Ltd 2013-04-04
TAKTIC project–EU (govt): grant, 201304– FP7 grant €1.1m 2013-04-01
Serodus–SEVERAL: investment, 201303 IPO €0.5m at Oslo Stock Exchange 2013-03-25
AstraZeneca–Karolinska Institutet: drug development, 201303– collab establishment of joint Integrated Translational Research Centre in Stockholm 2013-03-21
Orion Corp–Gedeon Richter: CNS drugs, 201303– collab long-term discovery + developm of NCEs for cognitive disorders 2013-03-12
Premacure–Shire: investment, 201303 acquisition of Premacure AB 2013-03-12
Active Biotech–Investor AB: investment, 201303 capital increase SEK270m 6m new shares SEK45/share sold to Investor AB 2013-03-06
Nepa Gene–Cellectricon: electroporation technology, 201303– distribution of Cellaxess ACE system in Japan by Nepa Gene Co Ltd 2013-03-04
Novel Science (JP)–Cellectricon: Dynaflow system, 201303– distribution of Dynaflow Resolve system in Japan by Novel Science Co Ltd 2013-03-04
EpiTherapeutics–Merck (DE): investment, 201302 financing round Series A 1st closing totalling €5m incl returning investor Merck Serono Ventures 2013-02-27
EpiTherapeutics–SEVERAL: investment, 201302 financing round Series A 1st closing of €5m incl Novo Seeds + MS Ventures et al. 2013-02-27
Leo Pharma–4SC: drug discovery services, 201302– collab €1m upfront + €95m milestones + royalties r+d + commerc drugs for inflammatory skin diseases 2013-02-26
Quest Diagnostics–Danaher: investment, 201302–201304 acquisition of HemoCue business from Quest for $300m adusted for cash balance by Radiometer 2013-02-25
DiaGenic–SEVERAL: investment, 201303 private placement NOK30m 50m new shares NOK0.60/share 2013-02-15
Pfizer–Agilent: companion diagnostics, 201302– collab framework agreem for developm of companion tests for Pfizer drugs by Dako 2013-02-12
TATAA Biocenter–BioSistemika: lab software, 201302– distribution of GENEIO Diagnostics s/w + PlatR easy pipetting assistant by TATAA Biocenter 2013-02-01
Guangzhou Haoxin Instrument–CellCura: in viro fertilization technology, 201308 distribution existent in China by Haoxin 2013-01-17
Venter Group–CLC bio: bioinformatics, 201301– license extension for 5y for entire CLC bio bioinformatics suite to J Craig Venter Institute 2013-01-08
FIMM–Labcyte: acoustic liquid handling technology, 201301– supply + further use + developm in genetics research 2013-01-07
Lilly–Agilent: cancer companion diagnostics, 201301– collab framework agreem for developm of companion tests for oncology drugs by Dako 2013-01-07
Immunicum–Sweden (govt): grant, 2013 Vinnova grant SEK470k 2013-01-01
NeuroNova (SE)–Newron: investment, 2013 acquisition of NeuroNova by Newron 2013-01-01
Siemens–CellaVision: cell analysis technology, 201301– distribution ww of CellaVision products by Siemens Healthcare Diagnostics 2013-01-01
Sigma-Aldrich–Olink: research reagents, 2013– distribution of Duolink reagents by Sigma-Aldrich 2013-01-01
Agilent–System Dynamics: connectivity software, 201212 acquisition of IP + development team €na by Dako 2012-12-21
Nerre Therapeutics–SEVERAL: investment, 201212 financing round Series A £11.5m from Novo A/S + Advent Venture Partners 2012-12-19
Sartorius–MKS Instruments: cheminformatics, 201212– global marketing + distribution of Umetrics’ s/w for biopharma developm + manufacturing by SSB 2012-12-18
Viljavuuspalvelu–Eurofins: investment, 201212 acquisition 92.5% majority stake from Yara Suomi Oy + Nordkalk Oy Ab 2012-12-18
next pagenext page 1 2 3 4 5 6 7 8 9 10  next pagenext page


Picture [LSUS] – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

» top